menu
    • menu

    Company profile for Rubicon Research

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Rubicon Research is a pioneer Drug Delivery Technology company based in India with significant experience in the field of formulation development. Rubicon has developed many differentiated products which are protected by patents and are available for out licensing. Rubicon also provides a full spectrum of development services from pre-formulation to registration.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rubicon Researchindia-flag Flag
    Country
    Country
    India
    Address
    Address
    221,Annexe Building ,Goregaon-Mulund Link Road,
    Telephone
    Telephone
    91 226 141 4000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.rubicon.co.in/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rubin Research’s Generics Ibuprofen Receives Approval in US
    Rubin Research’s Generics Ibuprofen Receives Approval in US

    05 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220239

    FDA
    05 Mar 2026
    Share Share
    Rubin Research’s Generics Cetirizine HCl Receives Approval in US
    Rubin Research’s Generics Cetirizine HCl Receives Approval in US

    25 Feb 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220335

    FDA
    25 Feb 2026
    Share Share
    Rubin’s Generics Rimegepant Receives Tentative Approval in US
    Rubin’s Generics Rimegepant Receives Tentative Approval in US

    14 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219440

    FDA
    14 Jan 2026
    Share Share
    Rubicon’s Generics Chlorpromazine HCl Receives Approval in US
    Rubicon’s Generics Chlorpromazine HCl Receives Approval in US

    10 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216678

    FDA
    10 Oct 2025
    Share Share
    General Atlantic Singapore Transfers 3.49M Rubicon Research Share
    General Atlantic Singapore Transfers 3.49M Rubicon Research Share

    08 Oct 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/general-atlantic-singapore-transfers-3-49-million-rubicon-research-shares-ahead-of-ipo/

    EXPRESSPHARMA
    08 Oct 2025
    Share Share
    Rubicon Research Secures Rs 140 Cr Investment From TIMF & 360 ONE
    Rubicon Research Secures Rs 140 Cr Investment From TIMF & 360 ONE

    22 Sep 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/rubicon-research-receives-rs-140-cr-fund-from-timf-holdings-360-one/

    EXPRESSPHARMA
    22 Sep 2025
    Share Share

    FDA Orange Book

    read-more
    read-more

    01

    Brand Name : ACETAZOLAMIDE

    India
    DCAT Week
    Not Confirmed
    arrow

    Brand Name : ACETAZOLAMIDE

    India
    DCAT Week
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ACETAZOLAMIDE

    Rubicon Research

    Dosage Form : TABLET; ORAL

    Proprietary Name : ACETAZOLAMIDE

    Dosage Strength : 125MG

    Approval Date : 2021-08-19

    Application Number : 215101

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : ACETAZOLAMIDE

    India
    DCAT Week
    Not Confirmed
    arrow

    Brand Name : ACETAZOLAMIDE

    India
    DCAT Week
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ACETAZOLAMIDE

    Rubicon Research

    Dosage Form : TABLET; ORAL

    Proprietary Name : ACETAZOLAMIDE

    Dosage Strength : 250MG

    Approval Date : 2021-08-19

    Application Number : 215101

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : ACYCLOVIR

    India
    DCAT Week
    Not Confirmed
    arrow

    Brand Name : ACYCLOVIR

    India
    DCAT Week
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    ACYCLOVIR

    Rubicon Research

    Dosage Form : SUSPENSION; ORAL

    Proprietary Name : ACYCLOVIR

    Dosage Strength : 200MG/5ML

    Approval Date : 2022-08-18

    Application Number : 215724

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : AMANTADINE HYDROCHLO...

    India
    DCAT Week
    Not Confirmed
    arrow

    Brand Name : AMANTADINE HYDROCHLO...

    India
    DCAT Week
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    AMANTADINE HYDROCHLORIDE

    Rubicon Research

    Dosage Form : CAPSULE; ORAL

    Proprietary Name : AMANTADINE HYDROCHLORIDE

    Dosage Strength : 100MG

    Approval Date : 2020-05-21

    Application Number : 212044

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : AMIODARONE HYDROCHLO...

    India
    DCAT Week
    Not Confirmed
    arrow

    Brand Name : AMIODARONE HYDROCHLO...

    India
    DCAT Week
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    AMIODARONE HYDROCHLORIDE

    Rubicon Research

    Dosage Form : TABLET; ORAL

    Proprietary Name : AMIODARONE HYDROCHLORIDE

    Dosage Strength : 200MG

    Approval Date : 2008-11-06

    Application Number : 78578

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : AMIODARONE HYDROCHLO...

    India
    DCAT Week
    Not Confirmed
    arrow

    Brand Name : AMIODARONE HYDROCHLO...

    India
    DCAT Week
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    AMIODARONE HYDROCHLORIDE

    Rubicon Research

    Dosage Form : TABLET; ORAL

    Proprietary Name : AMIODARONE HYDROCHLORIDE

    Dosage Strength : 100MG

    Approval Date : 2021-02-26

    Application Number : 78578

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : AMIODARONE HYDROCHLO...

    India
    DCAT Week
    Not Confirmed
    arrow

    Brand Name : AMIODARONE HYDROCHLO...

    India
    DCAT Week
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : AB

    AMIODARONE HYDROCHLORIDE

    Rubicon Research

    Dosage Form : TABLET; ORAL

    Proprietary Name : AMIODARONE HYDROCHLORIDE

    Dosage Strength : 400MG

    Approval Date : 2021-02-26

    Application Number : 78578

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : AB

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : AMITRIPTYLINE HYDROC...

    India
    DCAT Week
    Not Confirmed
    arrow

    Brand Name : AMITRIPTYLINE HYDROC...

    India
    DCAT Week
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : BX

    AMITRIPTYLINE HYDROCHLORIDE

    Rubicon Research

    Dosage Form : TABLET; ORAL

    Proprietary Name : AMITRIPTYLINE HYDROCHLOR...

    Dosage Strength : 10MG

    Approval Date : 2023-05-01

    Application Number : 215376

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : BX

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : AMITRIPTYLINE HYDROC...

    India
    DCAT Week
    Not Confirmed
    arrow

    Brand Name : AMITRIPTYLINE HYDROC...

    India
    DCAT Week
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : BX

    AMITRIPTYLINE HYDROCHLORIDE

    Rubicon Research

    Dosage Form : TABLET; ORAL

    Proprietary Name : AMITRIPTYLINE HYDROCHLOR...

    Dosage Strength : 25MG

    Approval Date : 2023-05-01

    Application Number : 215376

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : BX

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : AMITRIPTYLINE HYDROC...

    India
    DCAT Week
    Not Confirmed
    arrow

    Brand Name : AMITRIPTYLINE HYDROC...

    India
    DCAT Week
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RLD : No

    TE Code : BX

    AMITRIPTYLINE HYDROCHLORIDE

    Rubicon Research

    Dosage Form : TABLET; ORAL

    Proprietary Name : AMITRIPTYLINE HYDROCHLOR...

    Dosage Strength : 50MG

    Approval Date : 2023-05-01

    Application Number : 215376

    RX/OTC/DISCN : RX

    RLD : No

    TE Code : BX

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    Inspections and registrations

    Upload your audits for free, ask us

    FDA

    read-more
    read-more

    01

    FDA Audited

    USA
    DCAT Week
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    DCAT Week
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2025-03-20

    Rubicon Research

    City : Thane

    State :

    Country/Area : India

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2025-03-20

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    DCAT Week
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    DCAT Week
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2024-03-08

    Rubicon Research

    City : Thane

    State :

    Country/Area : India

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2024-03-08

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    DCAT Week
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    DCAT Week
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2023-11-03

    Rubicon Research

    City : Concord

    State :

    Country/Area : Canada

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2023-11-03

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    DCAT Week
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    DCAT Week
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2023-01-27

    Rubicon Research

    City : Thane

    State :

    Country/Area : India

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2023-01-27

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    DCAT Week
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    DCAT Week
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2018-10-18

    Rubicon Research

    City : Concord

    State :

    Country/Area : Canada

    Zip :

    District :

    Center :

    Project Area : Bioresearch Monitoring

    District Decision : No Action Indicated

    Inspection End Date : 2018-10-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    DCAT Week
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    DCAT Week
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2017-11-20

    Rubicon Research

    City : Thane

    State :

    Country/Area : India

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2017-11-20

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    07

    FDA Audited

    USA
    DCAT Week
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    DCAT Week
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2016-07-27

    Rubicon Research

    City : Concord

    State :

    Country/Area : Canada

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2016-07-27

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    08

    FDA Audited

    USA
    DCAT Week
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    DCAT Week
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-03-13

    Rubicon Research

    City : Thane

    State :

    Country/Area : India

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2015-03-13

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    09

    FDA Audited

    USA
    DCAT Week
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    DCAT Week
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-04-11

    Rubicon Research

    City : Thane

    State :

    Country/Area : India

    Zip :

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2013-04-11

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact Rubicon Research Private Limited and get a quotation

    Rubicon Research Private Limited is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Dextromethorphan bulk with DMF offered by Rubicon Research Private Limited

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search